Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 47.4% on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares traded hands during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The firm has a 50 day moving average price of C$0.08 and a 200 day moving average price of C$0.06. The stock has a market cap of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Most active stocks: Dollar volume vs share volume
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- CD Calculator: Certificate of Deposit Calculator
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Dividend Capture Strategy: What You Need to Know
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
